Medicare Enrolled

Dr. David Dimarco, O.D.

Optometrist · Wexford, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
7000 STONEWOOD DR STE 200, Wexford, PA 15090
7249404001
Registered in NPPES since 2007
NPI: 1912104811 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dimarco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dimarco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dimarco

Dr. David Dimarco is an optometrist in Wexford, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dimarco performed 859 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Dimarco received a total of $3,222 from 28 pharmaceutical and/or device companies across 134 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dimarco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 17% volume in PA $3,222 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
859
Medicare services
Top 17% in PA for optometrist
Not available
Unique patients (not deduplicated)
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
357 $78 $135
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
181 $60 $100
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
115 $28 $80
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
88 $23 $80
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
47 $46 $100
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $40 $70
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
14 $81 $175
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
12 $6 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,222
Total received (2018-2024)
Avg $460/year across 7 years
Top 10% in PA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
134
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$896
2023
$593
2022
$614
2021
$97
2020
$116
2019
$411
2018
$496

Payments by company (2024)

Bausch & Lomb Americas Inc.
$345
ABBVIE INC.
$177
Tarsus Pharmaceuticals, Inc.
$76
Oyster Point Pharma, Inc.
$54
Harrow Eye, LLC
$48
Alcon Vision LLC
$44
Glaukos Corporation
$36
Johnson & Johnson Vision Care, Inc.
$27
CooperVision Inc.
$25
Dompe US, Inc.
$22
Thea Pharma Inc.
$21
RxSight Inc
$20
Top 3 companies account for 66.8% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$593
Johnson & Johnson Vision Care, Inc.
$451
Sun Pharmaceutical Industries Inc.
$341
Oyster Point Pharma, Inc.
$253
ABBVIE INC.
$197
Allergan Inc.
$193
Bausch & Lomb, a division of Bausch Health US, LLC
$159
Shire North American Group Inc
$156
Alcon Vision LLC
$150
Novartis Pharmaceuticals Corporation
$78
Tarsus Pharmaceuticals, Inc.
$76
RxSight Inc
$66
Kala Pharmaceuticals, Inc.
$66
CooperVision Inc.
$56
Harrow Eye, LLC
$48
Horizon Therapeutics plc
$44
Eyevance Pharmaceuticals LLC
$41
Allergan, Inc.
$38
Glaukos Corporation
$36
AbbVie Inc.
$36
Mallinckrodt Hospital Products Inc.
$27
Dompe US, Inc.
$22
Thea Pharma Inc.
$21
NovaBay Pharmaceuticals, Inc.
$18
Aerie Pharmaceuticals, Inc.
$16
Mallinckrodt Enterprises LLC
$16
TissueTech, Inc.
$13
Mallinckrodt LLC
$12
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Acuvue · Avenova · BESIVANCE · BIOTRUE ONE DAY · BROMSITE · BTOD · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · Cequa · Clariti Contact Lens · DAILIES · DUREZOL · Flarex · HYDRUS Microstent · INFUSE · INFUSE MULTIFOCAL · INVELTYS · IYUZEH · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · MiSight Contact Lens · MyDay Contact Lens · OXERVATE · PROLENSA · Prokera · RESTASIS · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · TEPEZZA · TOTAL30 · TYRVAYA · ULTRA MULTIFOCAL TORIC · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · iStent Trabecular Micro-Bypass System Model iS3 · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optometrist in Wexford?
Compare optometrists in the Wexford area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists in nearby ZIP areas
368
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
AHN WEXFORD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dimarco is a mixed practice specialist, with above-average Medicare volume (top 17% in PA), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dimarco experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Dimarco performed 357 comprehensive eye exam, established patient services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dimarco receive payments from pharmaceutical companies?
Yes. Dr. Dimarco received a total of $3,222 from 28 companies across 134 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dimarco's costs compare to other optometrists in Wexford?
Dr. Dimarco's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dimarco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →